Literature DB >> 19596944

Impact of interstitial lung disease on survival for patients with non-small cell lung cancer.

Kunihiko Miyazaki1, Hiroaki Satoh, Koichi Kurishima, Ryota Nakamura, Hiroichi Ishikawa, Katsunori Kagohashi, Gen Ohara, Nobuyuki Hizawa.   

Abstract

BACKGROUND: Interstitial lung disease (ILD) and lung cancer are two of the most common respiratory diseases. The aim of this study was to demonstrate the prognostic significance of presence of ILD in patients with non-small cell lung cancer (NSCLC). PATIENTS AND METHODS: All the patients with NSCLC who were admitted to our hospitals over a 23-year period up to 2008 were retrospectively analyzed.
RESULTS: During the study period, 2,165 NSCLC patients were consecutively admitted to our hospitals. Among them, 53 (2.4%) patients were diagnosed as having both NSCLC and ILD. In uni- and multivariate analysis, female gender, early stage, good PS, and surgery were favorable prognostic factors. The presence of ILD was confirmed as an unfavorable prognostic factor.
CONCLUSION: Existing ILD adversely affects the outcome of NSCLC. When deciding whether or not to offer a standard therapy which may increase treatment-related mortality, the patient's medical condition, including ILD, should be taken into consideration.

Entities:  

Mesh:

Year:  2009        PMID: 19596944

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Serum KL-6 levels in lung cancer patients with or without interstitial lung disease.

Authors:  Kunihiko Miyazaki; Koichi Kurishima; Katsunori Kagohashi; Mio Kawaguchi; Hiroichi Ishikawa; Hiroaki Satoh; Nobuyuki Hizawa
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 2.  Lung cancer and interstitial lung disease: a literature review.

Authors:  Jean-Marc Naccache; Quentin Gibiot; Isabelle Monnet; Martine Antoine; Marie Wislez; Christos Chouaid; Jacques Cadranel
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

3.  Outcomes of Older Patients with Pulmonary Fibrosis and Non-Small Cell Lung Cancer.

Authors:  Stacey-Ann Whittaker Brown; Maria Padilla; Grace Mhango; Emanuela Taioli; Charles Powell; Juan Wisnivesky
Journal:  Ann Am Thorac Soc       Date:  2019-08

4.  Impact of smoking on mortality of patients with non-small cell lung cancer.

Authors:  Seung Jun Lee; Jinwoo Lee; Young Sik Park; Chang-Hoon Lee; Sang-Min Lee; Jae-Joon Yim; Chul-Gyu Yoo; Sung Koo Han; Young Whan Kim
Journal:  Thorac Cancer       Date:  2014-01-02       Impact factor: 3.500

5.  Impact of concomitant idiopathic pulmonary fibrosis on prognosis in lung cancer patients: A meta-analysis.

Authors:  Haoyu Wang; Ruiyuan Yang; Jing Jin; Zhoufeng Wang; Weimin Li
Journal:  PLoS One       Date:  2021-11-12       Impact factor: 3.240

Review 6.  Which patients benefit most from stereotactic body radiotherapy or surgery in medically operable non-small cell lung cancer? An in-depth look at patient characteristics on both sides of the debate.

Authors:  Gail Wan Ying Chua; Kevin Lee Min Chua
Journal:  Thorac Cancer       Date:  2019-08-06       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.